Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  TCS gains on launching CCT Platform on its Advanced Drug Development Suite

17-Oct2017

TCS gains on launching CCT Platform on its Advanced Drug Development Suite

Tata Consultancy Services (TCS) is currently trading at Rs. 2601.85, up by 16.75 points or 0.65% from its previous closing of Rs. 2585.10 on the BSE.

The scrip opened at Rs. 2586.00 and has touched a high and low of Rs. 2612.95 and Rs. 2581.10 respectively. So far 6,235 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2707.40 on 06-Jun-2017 and a 52 week low of Rs. 2054.70 on 15-Nov-2016.

Last one week high and low of the scrip stood at Rs. 2612.95 and Rs. 2457.70 respectively. The current market cap of the company is Rs. 4,97,829.00 crore.

The promoters holding in the company stood at 73.57%, while Institutions and Non-Institutions held 22.26% and 4.18% respectively.

Tata Consultancy Services has launched Connected Clinical Trials (CCT), an innovative Software as a Service (SaaS) platform that enables pharmaceutical companies to significantly transform patient engagement in clinical trials and improve the efficiency and accountability of the clinical supply process.

CCT is part of TCS' Advanced Drug Development (ADD) suite that offers a wide range of cloud based clinical services, including Clinical Data Management, Metadata Management, Pharmacovigilance, and Data Analytics and Insights.

ADD is powered by a cognitive engine called 'Decision Fabric' that enables automation of complex business processes. ADD leverages the best of cloud architecture and intuitive user experience design in compliance with good clinical practice quality guidelines (GCP) and privacy regulations.

Tata Consultancy Services (TCS) is an IT services, consulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. The company offers a consulting-led, integrated portfolio of IT, BPS, infrastructure, engineering and assurance services.



Related News

View all news

United Bank of India shines on getting nod to raise Rs 1,500 crore by various means

United Bank of India is currently trading at Rs. 11.05, up by 0.50 points or 4.74% from its previous closing of Rs. 10.55 on the BSE.The scrip opened at Rs. 10.85 and has touched a high and low of Rs.......

Pondy Oxides & Chemicals gains on planning to merge Meloy Metals with itself

Pondy Oxides & Chemicals is currently trading at Rs. 319.80, up by 1.85 points or 0.58% from its previous closing of Rs. 317.95 on the BSE.The scrip opened at Rs. 317.80 and has touched a high......

Venky's slips on reporting 41.52% fall in Q4 net profit

Venky's  (India) is currently trading at Rs. 1766.00, down by 56.15 points or 3.08% from its previous closing of Rs. 1822.15 on the BSE.The scrip opened at Rs. 1817.00 and has touched a high and......

Top News

View all news

SRF, NIIT Technologies and United Bank of India to see some action today

SRF has entered into a definitive agreement to sell its Engineering Plastics Business to DSM, the Life Sciences and Materials Sciences Company in an all-cash transaction, amounting to Rs 320 crore. The......

NIIT Technologies concludes sale of 88.99% stake in ESRI India Technologies

NIIT Technologies has concluded the sale of 88.99% equity shares in ESRI India Technologies, India to Environment Systems Research Institute Inc., USA. Consequent to above sale, ESRI India Technologies,......

United Bank of India to raise Rs 1,500 crore by various means

United Bank of India has received approval to raise equity capital not exceeding Rs 1,500 crore in one or more tranches during the financial year by way of Qualified Institutions Placement, Public Issue,......